JPWO2022107755A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022107755A5 JPWO2022107755A5 JP2022563761A JP2022563761A JPWO2022107755A5 JP WO2022107755 A5 JPWO2022107755 A5 JP WO2022107755A5 JP 2022563761 A JP2022563761 A JP 2022563761A JP 2022563761 A JP2022563761 A JP 2022563761A JP WO2022107755 A5 JPWO2022107755 A5 JP WO2022107755A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyloxy
- hydrogen atom
- acridinium salt
- formula
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020191118 | 2020-11-17 | ||
| JP2020191118 | 2020-11-17 | ||
| PCT/JP2021/042049 WO2022107755A1 (ja) | 2020-11-17 | 2021-11-16 | 新規アクリジニウム塩およびその製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2022107755A1 JPWO2022107755A1 (https=) | 2022-05-27 |
| JPWO2022107755A5 true JPWO2022107755A5 (https=) | 2024-09-10 |
| JP7685522B2 JP7685522B2 (ja) | 2025-05-29 |
Family
ID=81707996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022563761A Active JP7685522B2 (ja) | 2020-11-17 | 2021-11-16 | 新規アクリジニウム塩およびその製造方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230278960A1 (https=) |
| EP (1) | EP4249077A4 (https=) |
| JP (1) | JP7685522B2 (https=) |
| CN (1) | CN116783167A (https=) |
| AR (1) | AR124071A1 (https=) |
| WO (1) | WO2022107755A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250129029A1 (en) * | 2021-09-06 | 2025-04-24 | Osaka University | Acridine compound |
| CN116082361B (zh) * | 2023-04-11 | 2023-06-13 | 和鼎（南京）医药技术有限公司 | 一种制备玛巴洛沙韦中间体和玛巴洛沙韦的方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2448766T3 (es) | 2008-07-25 | 2014-03-17 | Viiv Healthcare Company | Profármacos de dolutegravir |
| WO2010011819A1 (en) | 2008-07-25 | 2010-01-28 | Smithkline Beecham Corporation | Chemical compounds |
| KR101733625B1 (ko) | 2008-12-11 | 2017-05-10 | 시오노기세야쿠 가부시키가이샤 | 카르바모일피리돈 ｈｉｖ 인테그라제 억제제 및 중간체의 합성 |
| CN102245572B (zh) | 2008-12-11 | 2015-03-25 | 盐野义制药株式会社 | 氨甲酰基吡啶酮hiv整合酶抑制剂的方法和中间体 |
| TWI518084B (zh) | 2009-03-26 | 2016-01-21 | 鹽野義製藥股份有限公司 | 哌喃酮與吡啶酮衍生物之製造方法 |
| ES2608377T3 (es) | 2010-08-05 | 2017-04-10 | Shionogi & Co., Ltd. | Procedimiento de preparación de un compuesto que tiene actividad inhibidora de la integrasa del HIV |
| US9573965B2 (en) | 2013-02-19 | 2017-02-21 | Aurobindo Pharma Ltd | Process for the preparation of Dolutegravir |
| US9856270B2 (en) | 2013-07-17 | 2018-01-02 | Ratiopharm Gmbh | Dolutegravir salts |
| WO2015019310A1 (en) | 2013-08-07 | 2015-02-12 | Mylan Laboratories Ltd | Process for the preparation of dolute-gravir and intermediates thereof |
| ES2770050T3 (es) | 2014-01-21 | 2020-06-30 | Laurus Labs Ltd | Nuevo procedimiento para la preparación de dolutegravir y sus sales farmacéuticamente aceptables |
| WO2015177537A1 (en) | 2014-05-20 | 2015-11-26 | Cipla Limited | Process for preparing polycyclic carbamoyl pyridone derivatives and intermediates thereof |
| WO2016092527A1 (en) | 2014-12-12 | 2016-06-16 | Sun Pharmaceutical Industries Limited | A process for the preparation of dolutegravir |
| US10730888B2 (en) | 2015-02-06 | 2020-08-04 | Mylan Laboratories Limited | Process for the preparation of dolutegravir |
| SG11201708721XA (en) | 2015-04-28 | 2017-11-29 | Shionogi & Co | Substituted polycyclic pyridone derivative and prodrug thereof |
| WO2016196816A1 (en) * | 2015-06-03 | 2016-12-08 | The University Of North Carolina At Chapel Hill | Photoredox-catalyzed direct c-h functionalization of arenes |
| SG11201804348SA (en) | 2015-12-15 | 2018-06-28 | Shionogi & Co | Medicine for treating influenza characterized by comprising combination of cap-dependent endonuclease inhibitor with anti-influenza drug |
| CN111386276B (zh) * | 2017-10-06 | 2023-06-23 | 盐野义制药株式会社 | 制备取代的多环吡啶酮衍生物的立体选择性方法 |
| WO2020176804A1 (en) | 2019-02-28 | 2020-09-03 | The University Of North Carolina At Chapel Hill | Direct aromatic carbon-oxygen and carbon-hydrogen bond functionalization via organic photoredox catalyst |
-
2021
- 2021-11-16 WO PCT/JP2021/042049 patent/WO2022107755A1/ja not_active Ceased
- 2021-11-16 AR ARP210103161A patent/AR124071A1/es not_active Application Discontinuation
- 2021-11-16 CN CN202180077224.0A patent/CN116783167A/zh active Pending
- 2021-11-16 JP JP2022563761A patent/JP7685522B2/ja active Active
- 2021-11-16 EP EP21894629.1A patent/EP4249077A4/en active Pending
-
2023
- 2023-05-11 US US18/196,255 patent/US20230278960A1/en active Pending